Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q16637 (
SMA
)
8,107
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The purpose of this study was to investigate whether local mechanisms of blood flow autoregulation mediate vasoconstriction during the early development of renal hypertension. Anesthetized rats were instrumented with Doppler flow probes on the celiac (CA), superior mesenteric (
SMA
), and renal arteries to measure flow velocity in these vessels. Acute two-kidney, one clip renal hypertension was produced by inflating a pneumatic occluder on the left renal artery to reduce flow velocity by 50%. Two hours after
renal artery stenosis
(RAS), femoral artery pressure (AP) was increased by 35%, CA resistance by 45%, and
SMA
resistance by 57%. No increases were observed in AP or in CA and
SMA
resistances for sham-operated, control rats. To determine if autoregulation contributed to the increase in
SMA
resistance, we protected the
SMA
vasculature from the increased arterial pressure by servocontrolled inflation of a pneumatic cuff implanted around the
SMA
. Although normalizing
SMA
pressure with the protective cuff significantly reduced (p less than 0.05) the increase in
SMA
resistance that occurred after RAS,
SMA
resistance remained elevated above control levels. These results suggest that (1) reduced intensity of
SMA
constriction produced by protection of the
SMA
is due to inhibition of a local autoregulatory mechanism that is contributing to the increase in
SMA
resistance during the acute development of renal hypertension, and (2) maintenance of elevated
SMA
resistance during protection from increased AP is the result of pressure-independent mechanisms that are activated subsequent to
renal artery stenosis
.
...
PMID:Autoregulation and vasoconstriction in the intestine during acute renal hypertension. 399 21
This clinical trial aimed to prospectively investigate the morphological structure of infrarenal abdominal aortic aneurysms (AAA) to establish a valid dataset in the preoperative assessment supporting either the conventional or endovascular (TPEG) surgical approach. Regarding both the general feasibility testing and safe TPEG placing, all the anatomic AAA data must already be measured preprocedurally, due to the necessity for conversion as a frequent consequence of an intraprocedural failure. Between January 1993 and June 1995, all the patients (n = 159) admitted for elective AAA repair, were prospectively analysed. Graded on the basis of these measurements we developed a new AAA classification system supporting the kind of the surgical procedure (standard) approach vs. TPEG). Three different types of AAA were clearly defined. Due to morphological AAA criteria, 86 out of 159 patients (54.1%) might be suitable for TPEG (Type I, IIA and IIB). An infrarenal (proximal) neck < 15 mm, an infrarenal aortic diameter > 24 mm or an extension of the aneurysm to the iliac bifurcation are considered to be exclusion criteria for TPEG placement. In consideration of relevant co-morbidities (e.g.
renal artery stenosis
,
SMA
occlusion, iliac occlusive disease, simultaneous operations) only 43 out 159 patients (27.1%) were good candidates for TPEG. In general, smaller AAA are more appropriate for TPEG repair due to better proximal and distal fixation. As a consequence, indication criteria for AAA repair must not be expanded to smaller AAA.
...
PMID:[Infrarenal abdominal aortic aneurysm: morphological classification as decision aid for therapeutic procedures]. 901 30